On October 15, 2009
Immunomedics Ignored, HGS Adored as Annual Rheumatology Confab Kicks Off
The American College of Rheumatology’s annual confab kicks off this weekend, and one item not on the menu is detailed Phase IIb data for Immunomedics and partner UCB’s lupus drug epratuzumab. Meanwhile Human Genome Sciences’ lupus drug Benlysta looks to be the belle of the ball.
0 Comments